Thema
Journal Article
161
Research Support, Non-U.S. Gov't
104
Antibodies, Viral
49
Antibodies, Neutralizing
41
Research Support, N.I.H., Extramural
39
Spike Glycoprotein, Coronavirus
32
COVID-19
29
SARS-CoV-2
28
615
27
A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d)
27
che
27
A61P: Specific therapeutic activity of chemical compounds or medicinal preparations
26
spike protein, SARS-CoV-2
21
Letter
19
Biology
17
570
16
Angiotensin-Converting Enzyme 2
14
EC 3.4.17.23
14
COVID-19 Vaccines
12
MERS-CoV
12
RNA, Viral
12
Viral Vaccines
12
Cytokines
11
Receptors, Virus
9
ACE2 protein, human
8
Epitopes, T-Lymphocyte
8
coronavirus
8
Epitopes
7
Immunoglobulin G
7
Nucleocapsid Proteins
7
Vaccines, Synthetic
7
Antiviral Agents
6
Broadly Neutralizing Antibodies
6
EC 3.4.15.1
6
Peptidyl-Dipeptidase A
6
82115-62-6
5
Antibodies, Monoclonal
5
Antigens, Viral
5
Comment
5
Coronavirus Nucleocapsid Proteins
5
Interferon Type I
5
Interferon-gamma
5
MERS
5
Recombinant Proteins
5
Review
5
Viral Proteins
5
mouse model
5
C07D: Heterocyclic compounds (macromolecular compounds c08)
4
C07K: Peptides (peptides containing β-lactam rings c07d;cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, c07d;ergot alkaloids of the cyclic peptide type c07d0519020000; single cell proteins, enzymes c12n;genetic engineering processes for obtaining peptides c12n0015000000)
4
Dipeptidyl Peptidase 4
4
mehr ...